BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11550502)

  • 21. [Pefloxacin mesylate--clinical effectiveness in various forms of infectious-inflammatory diseases].
    Pozdniakova VP; Nestetrova LIa; Smirnova LB; Iakovlev VP; Blatun LA; Koshil' OI; Fedorov SM; Bakalova LA; Strachunskiĭ LS; Kurmanova KB
    Antibiot Khimioter; 1997; 42(7):20-3. PubMed ID: 9334143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the effectiveness of the use of pefloxacin in combined radiation-thermal injury].
    Makarov GF; Budagov RS; Moiseeva LA; Boldueva NG
    Antibiot Khimioter; 1995 Aug; 40(8):36-9. PubMed ID: 8713436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of joint toxicity from pefloxacin in the treatment of nephrotic syndrome in a child].
    Diouf B; Djoneidi M; Niang A; Diallo S; Moreira-Diop T; Bao O
    Dakar Med; 1996; 41(2):105-7. PubMed ID: 9827103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bacteremia and Pasteurella multocida pneumonia revealing HIV infection].
    Bernier C; Bouvard E; Saidi F; Parrot A; Meyniel D
    Rev Pneumol Clin; 1999 Dec; 55(6):403-6. PubMed ID: 10685476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pefloxacin versus cefuroxime axetil for single-dose therapy of acute uncomplicated lower urinary tract infections in women.
    Krcmery S; Hromec J; Gulla D
    J Chemother; 1995 Nov; 7 Suppl 4():168-9. PubMed ID: 8904145
    [No Abstract]   [Full Text] [Related]  

  • 26. Fluoroquinolones in children: poorly defined risk of joint damage.
    Prescrire Int; 2004 Oct; 13(73):184-6. PubMed ID: 15499700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of pefloxacin concentration in blood and sputum in the aged pneumonia patients with impairment of renal function].
    Ma L; Sun C; Wu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Oct; 24(10):596-8. PubMed ID: 11770420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fluoroquinolones in clinical practice. Pefloxacin (abaktal, peflacine)].
    Fomina IP; Iudin SM; Kashina LB
    Antibiot Khimioter; 1995; 40(11-12):70-7. PubMed ID: 8830644
    [No Abstract]   [Full Text] [Related]  

  • 29. [Abactal (pefloxacin) in the treatment of gonorrheal and mixed infections].
    Kisina VI
    Antibiot Khimioter; 1993 Dec; 38(12):42-3. PubMed ID: 8085909
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of pefloxacin in the treatment of patients with purulent wounds of soft tissues].
    Blatun LA; Puchkova LS; Navashin PS; Iakovlev VP; Svetykhin AM
    Antibiot Khimioter; 1999; 44(1):20-2. PubMed ID: 10095920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of pefloxacin in the treatment of complicated relapsing erysipelas].
    Kurmanova KB; Sulełmenova ZI; Sensatkhit K; Uteulin MN
    Antibiot Khimioter; 1997; 42(12):25-8. PubMed ID: 9480650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Application of new strategies in the treatment of patients with purulent sepsis complications].
    Medvets'kyĭ IeB; Sukhariev II; Kryzhevs'kyĭ VV; Nychytaĭlo MIu; Vlaĭkov HH; Steblyna VIe; Hyndych LO; Furmanenko OD
    Klin Khir; 2001 Jul; (7):62-4. PubMed ID: 11688292
    [No Abstract]   [Full Text] [Related]  

  • 33. Quinolones-induced acral erythema.
    Bonnetblanc JM; Bernard P
    Therapie; 1996; 51(5):601-2. PubMed ID: 9138405
    [No Abstract]   [Full Text] [Related]  

  • 34. Seven Achilles tendinitis including 3 complicated by rupture during fluoroquinolone therapy.
    Ribard P; Audisio F; Kahn MF; De Bandt M; Jorgensen C; Hayem G; Meyer O; Palazzo E
    J Rheumatol; 1992 Sep; 19(9):1479-81. PubMed ID: 1433021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic urticaria and monoclonal IgM gammopathy (Schnitzler syndrome): report of 11 cases treated with pefloxacin.
    Asli B; Bienvenu B; Cordoliani F; Brouet JC; Uzunhan Y; Arnulf B; Malphettes M; Rybojad M; Fermand JP
    Arch Dermatol; 2007 Aug; 143(8):1046-50. PubMed ID: 17709664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release of pefloxacin bonded on catheters after intraperitoneal implantation in mice.
    Carsenti-Etesse H; Forget B; Bensoussan M; Bensoussan F; Dellamonica P
    Drugs; 1995; 49 Suppl 2():304-6. PubMed ID: 8549342
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of norfloxacin or pefloxacin on the oral and intestinal microflora of bone marrow transplant patients.
    Giuliano M; Gentile G; Pantosti A; Micozzi A; Arcese W; Martino P
    J Chemother; 1989 Jul; 1(4 Suppl):726-7. PubMed ID: 16312609
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of subinhibitory concentrations of pefloxacin in infection in mice due to susceptible or resistant strains.
    Carsenti-Etesse H; Bensoussan M; Bensoussan F; Durant J; Pradier C; Mondain V; Bernard E; Dellamonica P
    Drugs; 1995; 49 Suppl 2():276-8. PubMed ID: 8549331
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pefloxacin in the treatment of the bone and joint infections].
    Maiello A; Dassio G; Calvo MM; Gramoni A
    Minerva Med; 1999; 90(1-2):33-7. PubMed ID: 10388461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effect of gentamicin and pefloxacin treatment on the late stages of mouse typhoid.
    Bonina L; Costa GB; Mastroeni P
    New Microbiol; 1998 Jan; 21(1):9-14. PubMed ID: 9497924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.